Cargando…

Pharmacokinetics of Hyperthermic Intrathoracic Chemotherapy following Pleurectomy and Decortication

In patients with pseudomyxoma peritonei or peritoneal mesothelioma, direct extension of disease through the hemidiaphragm may result in an isolated progression of tumor within the pleural space. We monitored the intrapleural and plasma levels of mitomycin C and doxorubicin by HPLC assay in order to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sugarbaker, Paul H., Stuart, O. Anthony, Eger, Christopher
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3328159/ https://www.ncbi.nlm.nih.gov/pubmed/22548052 http://dx.doi.org/10.1155/2012/471205

Ejemplares similares

Survival of pleurectomy-decortication and hyperthermic chemotherapy in mesothelioma
por: Ergönül, Ayşe Gül, et al.
Publicado: (2023)

Comparison of video-assisted pleurectomy/decortication surgery plus hyperthermic intrathoracic chemotherapy with VATS talc pleurodesis for the treatment of malignant pleural mesothelioma: A pilot study
por: Migliore, Marcello, et al.
Publicado: (2023)

Induction Chemotherapy Followed by Pleurectomy Decortication and Hyperthermic Intraoperative Chemotherapy (HITHOC) for Early-Stage Epitheliod Malignant Pleural Mesothelioma—A Prospective Report
por: Bongiolatti, Stefano, et al.
Publicado: (2021)

Strategies to reduce morbidity following pleurectomy and decortication for malignant pleural mesothelioma
por: Bou‐Samra, Patrick, et al.
Publicado: (2023)

Extrapleural pneumonectomy or pleurectomy/decortication for malignant pleural mesothelioma
por: Hasegawa, Seiki
Publicado: (2014)

Extended pleurectomy and decortication: Video atlas of operative steps
por: Ripley, R. Taylor, et al.
Publicado: (2021)

Pleurectomy decortication is the preferred surgical procedure in pleural mesothelioma
por: Lapidot, Moshe, et al.
Publicado: (2023)

Hyperthermic Intraoperative Thoracoabdominal Chemotherapy
por: Sugarbaker, Paul H., et al.
Publicado: (2012)

Extended Pleurectomy/Decortication for Malignant Pleural Mesothelioma: Humanitas’s Experience
por: Mangiameli, Giuseppe, et al.
Publicado: (2021)

Systematic review of quality of life following pleurectomy decortication and extrapleural pneumonectomy for malignant pleural mesothelioma
por: Schwartz, Rebecca M., et al.
Publicado: (2018)

Non‐incisional pleurectomy/decortication for malignant mesothelioma after cardiac surgery
por: Miura, Kentaro, et al.
Publicado: (2021)

Mesothelioma and Radical Surgery 2 (MARS 2): protocol for a multicentre randomised trial comparing (extended) pleurectomy decortication versus no (extended) pleurectomy decortication for patients with malignant pleural mesothelioma
por: Lim, Eric, et al.
Publicado: (2020)

The Excretion of Cisplatin after Hyperthermic Intrathoracic Chemotherapy
por: Larisch, Christopher, et al.
Publicado: (2023)

Anaesthetic management of cytoreductive surgery followed by hyperthermic intrathoracic chemotherapy perfusion
por: Kerscher, Christoph, et al.
Publicado: (2014)

Hyperthermic Intraperitoneal Chemotherapy with Melphalan: A Summary of Clinical and Pharmacological Data in 34 Patients
por: Bijelic, Lana, et al.
Publicado: (2012)

Quantitation and predictors of short-term mortality following extrapleural pneumonectomy, pleurectomy/decortication, and nonoperative management for malignant pleural mesothelioma
por: Wright, Christopher, et al.
Publicado: (2020)

Malignant pleural mesothelioma: Is reconstruction of the diaphragm necessary in left pleurectomy/decortication? A case report
por: Testori, Alberto, et al.
Publicado: (2019)

Commentary: Extended pleurectomy decortication: Step 1, standardized techniques; step 2, standardized documentation
por: Pass, Harvey I.
Publicado: (2021)

Feasibility and safety of extended pleurectomy/decortication for malignant pleural mesothelioma. A single group experience
por: Falanga, Francesco, et al.
Publicado: (2022)

Exposure to cisplatin in the operating room during hyperthermic intrathoracic chemotherapy
por: Markowiak, Till, et al.
Publicado: (2021)

Cytoreductive onco-surgery with combined hyperthermic intraperitoneal chemotherapy and hyperthermic intrathoracic chemotherapy: Perioperative challenges
por: Dattatri, Rohini, et al.
Publicado: (2019)

Systematic Review and Meta-Analysis of Pleurectomy/Decortication versus Extrapleural Pneumonectomy in the Treatment of Malignant Pleural Mesothelioma
por: Danuzzo, Federica, et al.
Publicado: (2022)

Surgical cytoreduction and hyperthermic intrathoracic chemotherapy for thymic tumours with pleural spread is effective on survival: results from the multicentre German hyperthermic intrathoracic chemotherapy study
por: Ried, Michael, et al.
Publicado: (2023)

Hyperthermic intrathoracic chemotherapy with cisplatin for ovarian cancer with pleural metastasis
por: Jun, Su Youn, et al.
Publicado: (2017)

Perioperative discordance in mesothelioma cell type after pleurectomy/decortication—a possible detrimental effect of neoadjuvant chemotherapy due to epithelial to mesenchymal transition?
por: Ventura, Luigi, et al.
Publicado: (2023)

Quality of Life Is Not Deteriorated After Extrapleural Pneumonectomy vs. (Extended) Pleurectomy/Decortication in Patients With Malignant Pleural Mesothelioma
por: Lauk, Olivia, et al.
Publicado: (2021)

Do we still need to debate the merits of pleurectomy/decortication vs. extrapleural pneumonectomy for malignant pleural mesothelioma?
por: Nakamura, Akifumi, et al.
Publicado: (2023)

A narrative review of hyperthermic intrathoracic chemotherapy for advanced lung cancer
por: Song, Kimberly, et al.
Publicado: (2021)

Locoregional control and toxicity after pleurectomy/decortication and intensity‐modulated pleural radiation therapy in patients with malignant pleural mesothelioma
por: Arrieta, Oscar, et al.
Publicado: (2020)

Cardiac output and oxygen delivery are affected by intraoperative hyperthermic intrathoracic chemotherapy
por: Scolletta, S, et al.
Publicado: (2008)

Anaesthetic management of extra-pleural pneumonectomy and hyperthermic intrathoracic chemotherapy procedure
por: Ramegowda, Jalaja Koppa, et al.
Publicado: (2015)

Present and future of hyperthermic intrathoracic chemotherapy (HITHOC) in thoracic surgical oncology
por: Migliore, Marcello
Publicado: (2021)

Hyperthermic intrathoracic chemotherapy (HITHOC): narrative review of the current literature, recommendations and future studies
por: Markowiak, Till, et al.
Publicado: (2021)

Protocol of a retrospective, multicentre observational study on hyperthermic intrathoracic chemotherapy in Germany
por: Markowiak, Till, et al.
Publicado: (2020)

Hyperthermic intrathoracic chemotherapy (HITHOC) should be included in the guidelines for malignant pleural mesothelioma
por: Migliore, Marcello, et al.
Publicado: (2021)

Salvage debulking surgery and hyperthermic intrathoracic chemotherapy for massive recurrent mesothelioma in the mediastinum
por: Poon, Shi Sum, et al.
Publicado: (2022)

Ki67 (MIB-1) as a Prognostic Marker for Clinical Decision Making Before Extended Pleurectomy Decortication in Malignant Pleural Mesothelioma
por: Belderbos, Robert A., et al.
Publicado: (2021)

VATS Pleurectomy Decortication Is a Reasonable Alternative for Higher Risk Patients in the Management of Malignant Pleural Mesothelioma: An Analysis of Short-Term Outcomes
por: Lee, Dong-Seok, et al.
Publicado: (2021)

A Trimodality, Four-Step Treatment including Chemotherapy, Pleurectomy/Decortication and Radiotherapy in Early-Stage Malignant Pleural Mesothelioma: A Single-Institution Retrospective Case Series Study
por: Vicidomini, Giovanni, et al.
Publicado: (2021)

Hyperthermic Intrathoracic Chemotherapy for Malignant Pleural Mesothelioma: The Forefront of Surgery-Based Multimodality Treatment
por: Aprile, Vittorio, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tg0ghm2ec2a201340jml1urd75